USD
+$0.00
(+0.00%
)At Close (As of Oct 14, 2025)
$18.84B
Market Cap
23.19
P/E Ratio
4.1
EPS
$113.87
52 Week High
$88.77
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $5.5B |
Total Revenue | $7.7B |
Cost Of Revenue | $2.2B |
Costof Goods And Services Sold | $2.2B |
Operating Income | $1.3B |
Selling General And Administrative | $2.9B |
Research And Development | $437M |
Operating Expenses | $4.2B |
Investment Income Net | - |
Net Interest Income | -$218M |
Interest Income | $218M |
Interest Expense | $218M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $996M |
Income Before Tax | $1B |
Income Tax Expense | $131M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $905M |
Comprehensive Income Net Of Tax | - |
Ebit | $1.3B |
Ebitda | $2.3B |
Net Income | $904M |
Field | Value (USD) |
---|---|
Total Assets | $21B |
Total Current Assets | $4.7B |
Cash And Cash Equivalents At Carrying Value | $526M |
Cash And Short Term Investments | $526M |
Inventory | $2.2B |
Current Net Receivables | $1.5B |
Total Non Current Assets | $17B |
Property Plant Equipment | $2.3B |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $4.6B |
Intangible Assets Excluding Goodwill | $4.6B |
Goodwill | $9B |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $430M |
Other Non Current Assets | - |
Total Liabilities | $8.9B |
Total Current Liabilities | $2.5B |
Current Accounts Payable | $195M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $863M |
Total Non Current Liabilities | $6.4B |
Capital Lease Obligations | - |
Long Term Debt | $5.3B |
Current Long Term Debt | $863M |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $6.2B |
Other Current Liabilities | $1.4B |
Other Non Current Liabilities | $744M |
Total Shareholder Equity | $12B |
Treasury Stock | - |
Retained Earnings | $11B |
Common Stock | $3.2M |
Common Stock Shares Outstanding | $204M |
Field | Value (USD) |
---|---|
Operating Cashflow | $1.5B |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $996M |
Capital Expenditures | $357M |
Change In Receivables | - |
Change In Inventory | $50M |
Profit Loss | - |
Cashflow From Investment | -$888M |
Cashflow From Financing | -$485M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | $196M |
Dividend Payout Common Stock | $196M |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | -$868M |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | $905M |
Field | Value (USD) |
---|---|
Gross Profit | $5.5B |
Total Revenue | $7.7B |
Cost Of Revenue | $2.2B |
Costof Goods And Services Sold | $2.2B |
Operating Income | $1.3B |
Selling General And Administrative | $2.9B |
Research And Development | $437M |
Operating Expenses | $4.2B |
Investment Income Net | - |
Net Interest Income | -$218M |
Interest Income | $218M |
Interest Expense | $218M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $996M |
Income Before Tax | $1B |
Income Tax Expense | $131M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $905M |
Comprehensive Income Net Of Tax | - |
Ebit | $1.3B |
Ebitda | $2.3B |
Net Income | $904M |
Field | Value |
---|---|
Ex Dividend Date | 2025-09-30 |
Declaration Date | 2025-08-27 |
Record Date | 2025-09-30 |
Payment Date | 2025-10-31 |
Amount | 0.24 |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Zimmer Biomet Holdings Inc. is a leading global medical device company focused on the design, manufacture, and marketing of a comprehensive portfolio of orthopedic reconstructive products, surgical and non-surgical solutions, and related services. Headquartered in Warsaw, Indiana, the company leverages a robust innovation pipeline and strategic partnerships to enhance patient outcomes and drive growth in the orthopedic, surgical, and dental markets. Zimmer Biomet’s commitment to innovation and excellence positions it as a key player in the healthcare industry, addressing the evolving needs of surgeons and healthcare professionals worldwide.